Merck & Co Inc (NYSE:MRK)

108.80
Delayed Data
As of Dec 09
 +0.02 / +0.02%
Today’s Change
71.97
Today|||52-Week Range
111.37
+41.96%
Year-to-Date
MRK Regular Dividend: MRK will begin trading ex-dividend on 12/14/22 with a $0.73 dividend payable to shareholders of record as of 12/15/22.
Merck (MRK) Dips More Than Broader Markets: What You Should Know
Dec 09 / Zacks.com - Paid Partner Content
Why Shares of Mirati Therapeutics Fell Wednesday
Dec 07 / MotleyFool.com - Paid Partner Content
Humana (HUM) Rises 23% in Past 6 Months: More Room to Run?
Dec 09 / Zacks.com - Paid Partner Content
3 High-Yielding Stocks That Are Up 27%-Plus This Year
Dec 07 / MotleyFool.com - Paid Partner Content
Early Q4 Earnings Results and Analyst Reports for Merck, Bristol-Myers & Deere
Dec 09 / Zacks.com - Paid Partner Content
Mirati (MRTX) Down After 1st-Line Lung Cancer Data on Adagrasib
Dec 07 / Zacks.com - Paid Partner Content
Merck (MRK) Is Up 2.36% in One Week: What You Should Know
Dec 09 / Zacks.com - Paid Partner Content
4 Defensive Stocks to Prepare Your Portfolio for a Recession
Dec 07 / Zacks.com - Paid Partner Content
Novartis' (NVS) PNH Candidate Achieves Study Objectives
Dec 08 / Zacks.com - Paid Partner Content
Is Adicet Bio (ACET) Stock Outpacing Its Medical Peers This Year?
Dec 07 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close108.78
Today’s open110.45
Day’s range108.75 - 111.36
Volume9,667,825
Average volume (3 months)8,744,649
Market cap$279.0B
Data as of 4:00pm ET, 12/09/2022

Growth & Valuation

Earnings growth (last year)+84.65%
Earnings growth (this year)+22.72%
Earnings growth (next 5 years)+11.00%
Revenue growth (last year)+1.86%
P/E ratio18.0
Price/Sales3.98
Price/Book7.28

Competitors

 Today’s
change
Today’s
% change
PFEPfizer-0.08-0.15%
ABBVAbbVie+0.03+0.02%
NVONovo Nordisk+1.13+0.88%
AZNAstraZeneca+0.71+1.03%
Data as of 4:00pm ET, 12/09/2022

Financials

Next reporting dateFebruary 2, 2023
EPS forecast (this quarter)$1.53
Annual revenue (last year)$48.9B
Annual profit (last year)$13.0B
Net profit margin25.24%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Kenilworth, New Jersey

Forecasts